This medication is provided under the supervision of a licensed prescriber
Weight management
In a study of Wegovy in people with or without type 2 diabetes, people taking 1.7 mg and 2.4 mg dosages lost an average of 2% of their body weight after one month
The weight loss timeline patterns observed with tirzepatide apply in principle to retatrutide as well, with significant results coming at higher therapeutic doses after proper titration
For men, obesity may be associated with: Low testosterone and reduced muscle mass Fertility challenges, including lower sperm count and motility Sexual health issues, such as erectile dysfunction and decreased libido Metabolic conditions, including type 2 diabetes, insulin resistance, and hypertension Sleep apnea and cardiovascular risks, both of which impact long-term health When men lose excess weight, they often see improvements in testosterone levels
At doses ranging from 40 to 200 mg taken twice daily, the highest weight reduction achieved was up to 11.7% compared to a 1.4% weight increase in the placebo group
